A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder

References

• Adler LA, Weisler RH, Goodman DW, Hamdani M, Niebler GE. 2009. Short term effects of lisdexamphetamine dimesylate on cardiovascular parameters in a 4 week clinical trial in adults with ADHD. J Clin Psychiatr 70(12):1652–1661.
   Google Scholar
• Adler L. 2009. Pharmacotherapy for adult ADHD. J Clin Psych 70(5):e12.
   Google Scholar
• American Thoracic Society, American College of Chest Physicians. 2003. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Resp Crit Care Med 167(2):211–277.
   Google Scholar
• Biederman J, Mick EO, Surman C, et al. 2007. Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with ADHD. BMC Psychiatry 7:49.
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Evans M, et al. 2010. How persistent is ADHD? A controlled 10 year follow up study of boys with ADHD. Psychiatry Res 177(3):299–304.
   Google Scholar
• Bybee KA, Prasad A. 2008. Stress related cardiomyopathy syndromes. Circulation 118:397–409.
   PubMed Web of Science ®Google Scholar
• Castle L, Aubert RE, Verbrugge RR, et al. 2007. Trends in medication treatment for ADHD. J Attention Disord 10(4):335–342.
   Google Scholar
• Cole CR, Foody JM, Blackstone EH, Lauer MS. 2000. Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med 132(7):552–555.
   Google Scholar
• Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, et al. 2011. ADHD Drugs and serious cardiovascular events in children and young adults. New Engl J Med. 17;365(20):1896–1904.
   Google Scholar
• Fayyad J, De Graaf R, Kessler R, et al. 2007. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409.
   PubMed Web of Science ®Google Scholar
• FDA Safety Announcement Nov 1, 2011. FDA drug safety communication: Safety review update of medications used to treat ADHD in children and young adults (available at www.fda.gov/Drugs/DrugSafety/ucm277770.htm).
   Google Scholar
• Gerhard T, Winterstein AG, Olfson M, et al. 2010. Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD. Pharmacoepidem Drug Saf 19(5):457–464.
   Google Scholar
• Gibbins C, Weiss M. 2007. Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults. Curr Psychiatry Rep 9(5):420–426.
   PubMedGoogle Scholar
• Gorelik DD, Hadley D, Myers J, Froelicher V. 2006. Is there a better way to predict death using heart rate recovery? Clin Cardiol 29(9):399–404.
   Google Scholar
• Habel L, Cooper W, Sox C, Chan A, Fireman R, Arbogast P, et al. 2011. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. J Am Med Assoc 306(24):2673–2683.
   Google Scholar
• Hammerness PG, Perrin JM, Shelley-Abrahamson R, Wilens, TE. 2011. Cardiovascular risk of stimulant treatment in pediatric attention deficit hyperactivity disorder: update and clinical recommendations. J Am Acad Child Adolesc Psychiatr 50(10): 978–990.
   Google Scholar
• Kessler RC, Adler L, Barkley R, et al. 2006. The prevalence and correlates of adult ADHD in the United States: Results from the national comorbidity survey replication. Am J Psychiatry 163(4):716–723.
   PubMed Web of Science ®Google Scholar
• Lang RM, et al. 2005. Recommendations for Chamber Quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463.
   PubMed Web of Science ®Google Scholar
• Lauer MS. 2009. Autonomic function and prognosis. Clev Clin J Med 76(Supp 2):S18–22.
   Google Scholar
• Mahon AD, Stephens BR, Cole AS. 2008. Exercise responses in boys with ADHD: effects of stimulant medication. J Attention Disord 12(2):170–176.
   Google Scholar
• Makris N, Biederman J, Monuteaux MC, Seidman LJ. 2009. Towards conceptualizing a neural systems-based anatomy of ADHD. Dev Neurosci 31(1–2):36–49.
   PubMed Web of Science ®Google Scholar
• Mora S, Redberg RF, Cui Y, et al. 2003. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. J Am Med Assoc 290(12):1600–1607.
   Google Scholar
• Movahed MR, Mostafizi K. 2008. Reverse or inverted left ventricular apical ballooning syndrome in a young woman in the setting of amphetamine use. Echocardiography 25(4):429–432.
   Google Scholar
• Nagueh SF, Appleton CP, Gillebert TC, et al. 2009. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10(2):165–193.
   Google Scholar
• Perrin JM, Friedman RA, Knilans TK; Black Box Working Group; Section on Cardiology and Cardiac Surgery. 2008. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics 122(2):451–453.
   Google Scholar
• Samuels JA, Franco K, Wan F, Sorof JM. 2006. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD. Pediatr Nephrol 21(1):92–95.
   PubMed Web of Science ®Google Scholar
• Schelleman H, Bilker WB, Kimmel SE, Daniel GW, Newcomb C, Guevara JP et al. 2012. Methylphenidate and risk of serious cardiovascular events in adults. Am J Psych Feb;169(2):178–185.
   Google Scholar
• Schubiner H, Hassunizadeh B, Kaczynski R. 2006. A controlled study of autonomic nervous system function in adults with ADHD treated with stimulant medications. J Attention Disord 10(2):205–211.
   Google Scholar
• Spencer TJ, Adler LA, McGough JJ, et al. 2007. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with ADHD. Biol Psychiatry 61(12):1380–1387.
   PubMed Web of Science ®Google Scholar
• Spencer TJ. 2008. Neurobiology and genetics of ADHD in adults. CNS Spectrums Suppl 13:5–7.
   Google Scholar
• Wilens T, Hammerness P, Biederman J, et al. 2005. Blood pressure changes associated with medication treatment of adults with ADHD. J Clin Psych 66(2):253–259.
   Google Scholar
• Wilens T, Prince J, Spencer T, Biederman J. 2006. Stimulants and sudden death: what is a physician to do? Pediatrics 118(3):1215–1219.
   Google Scholar
• Wilens TE, Zusman RM, Hammerness PG, et al. 2006. An open-label study of the tolerability of mixed amphetamine salts in adults with ADHD and treated primary essential hypertension. J Clin Psychiatr 67(5):696–702.
   Google Scholar
• Winterstein AG, Gerhard T, Shuster J, et al. 2007. Cardiac safety of central nervous system stimulants in children and adolescents with ADHD. Pediatrics 120(6):e1494–1501.
   Web of Science ®Google Scholar